Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.JHP Pharmaceuticals has established a multi-year manufacturing contract with an undisclosed pharmaceutical company.
Subscribe to our email newsletter
The company will be responsible for manufacturing and supply of an injectable anesthetic agent.
JHP president and CEO Stuart Hinchen said the company successfully completed an FDA (CBER) Pre-Approval Inspection in support of a biologic product launch for another long-term contract customer.
"Customers also rely on our extensive experience working with products throughout their life cycle which results in continuity of supply and program efficiencies," Hinchen added.